Archives of Blood Transfusion & Disorders

Cryoprecipitate Use Still Current in Hemophiliac Patients in the Congo

  • Open or Close Ngolet LO* and Elira Dokekias A

    Clinical Hematology Unit, Marien Ngouabi University, Congo

    *Corresponding author: Ngolet LO, Clinical Hematology Unit, Marien Ngouabi University, Brazzaville, Republic of Congo. BP: 32, Republic of Congo

Submission: November 06, 2017; Published: November 13, 2017

DOI: 10.31031/ABTD.2017.01.000506

ISSN: 2578-0239
Volume1 Issue2


Hemophiliac factor concentrates due to their high cost are not accessible for the population in low resource countries, therefore; cryoprecipitate remains the main replacement offer to hemophiliac population to control bleeding episodes.

Keywords: Cryoprecipitate; Hemophilia A; Congo

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com